首页|一例新生儿化脓性脑膜炎个体化治疗的药学监护

一例新生儿化脓性脑膜炎个体化治疗的药学监护

扫码查看
目的 探讨临床药师在新生儿化脓性脑膜炎中抗感染方案个体化治疗的作用.方法 临床药师从药物分布特点、科室病原菌回顾分析、用药原则及不良反应监护等方面提出个体化建议,患儿先后使用头孢哌酮舒巴坦、美罗培南、美罗培南+氟康唑、头孢克洛抗感染.结果 临床药师通过个体化用药建议及药学监护,患儿病情好转,治疗 19 d后患儿出院.结论 临床药师参与新生儿化脓性脑膜炎的诊疗过程,有助于提高患儿用药的安全性和有效性.
Pharmaceutical care of a case of neonatal purulent meningitis treated individually
Objective To explore the effect of clinical pharmacists in the individualized anti-infective treatment of neonatal purulent menin-gitis.Methods Clinical pharmacists put forward individual suggestions from the aspects of drug distribution characteristics,retrospective analysis of pathogenic bacteria in department,principle of drug use and monitoring of adverse reactions,the children were treated with cefoperazone sulbactam,meropenem,meropenem+fluconazole and cefaclor.Results Clinical pharmacists through individualized medication advice and pharmaceutical care,the children's condition improved,after 19 days of treatment,the children were discharged.Conclusion The participation of clinical pharma-cists in the diagnosis and treatment of neonatal purulent meningitis is helpful to improve the safety and efficacy of medication.

Clinical pharmacistNewbornPurulent meningitisIndividual treatment

王彩步、雷宏莹、赵倩、吴玮哲

展开 >

祥云县人民医院药剂科,云南大理 671000

遵义市妇幼保健院药剂科,贵州遵义 563000

广州市妇女儿童医疗中心药学部,广州 510623

临床药师 新生儿 化脓性脑膜炎 个体化治疗

2021年广东省医院协会药学科研专项基金

2021YSMS01

2023

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2023.21(12)
  • 6